Efficacy and Safety of Auto-FMT in Preventing aGVHD

Recruiting now · Not applicable

Conditions studied: Graft Versus Host Disease, Acute

In brief

To evaluation the efficacy and safety of autologous fecal bacteria transplantation in preventing acute graft versus host disease after haploidentical hematopoietic stem cell transplantation. Bone marrow transplant patients were recruited.

Key facts

Study ID

NCT04745221

Run by

The First Affiliated Hospital of Soochow University

People needed

100

Starts

2021-03-01

Expected to finish

2027-03-01

Last updated by the study team

2026-06-01

Who can join

Age: 18 and older, up to 60. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Haplo-HSCT patients; Bacteroidetes >0.1%; inverse Simpson diversity ≥2

You may not qualify if…

• Gastrointestinal diseases；Age>60; or Age<10；Probiotics or prebiotics were taken before enrollment

Where it is running

• Ye Zhao — Suzhou, Jiangsu, China (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.